Outstanding Regulatory Aspects in the European Pharmaceutical Market Panos KanavosElias Mossialos Leading Article 11 October 2012 Pages: 519 - 533
Angiotensin Converting Enzyme (ACE) Inhibitors and Heart Failure Fredrick AnderssonCharles ClineLeif Erhardt Review Article 11 October 2012 Pages: 535 - 550
Standard Cost Lists for Healthcare in Canada Philip JacobsNoralou P. Roos Review Article 11 October 2012 Pages: 551 - 560
Hospital Selection for Unit Cost Estimates in Multicentre Economic Evaluations Ron GoereeAmiram GafniGordon Blackhouse Original Research Article 11 October 2012 Pages: 561 - 572
A Model to Compute the Medical Cost of Patients in Intensive Care Carine ChaixIsabelle Durand-ZaleskiChristian Brun-Buisson Original Research Article 11 October 2012 Pages: 573 - 582
Costs of Diabetes Eva PaganoMassimo BrunettiLivio Garattini Original Research Article 11 October 2012 Pages: 583 - 595
Cost of Schizophrenia to UK Society Julian GuestRon F. Cookson Original Research Article 11 October 2012 Pages: 597 - 610
Olanzapine Rachel H. FosterKaren L. Goa Adis Pharmacoeconomic Drug Evaluation 11 October 2012 Pages: 611 - 640
A Review of Quality of Life in Alzheimer’s Disease Marianne GreerHelma Monteban Correpondence 11 October 2012 Pages: 641 - 641
The authors reply Sam S. SalekMelvyn D. WalkerAnthony J. Bayer Correpondence 11 October 2012 Pages: 641 - 644